Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-18
2007-09-18
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S465000, C548S466000, C546S112000, C546S139000, C546S146000, C514S412000
Reexamination Certificate
active
10861426
ABSTRACT:
Novel 2-pyrrolidin-2-yl-1H-indole compounds corresponding to formula (I)wherein R1, R2, R3and R4have the meanings given in the description, and pharmaceutical compositions containing these compounds, as well as processes for the preparation of such compounds and intermediate products of this process, and related methods of treatment.
REFERENCES:
patent: 6245761 (2001-06-01), Britton et al.
patent: WO-9311106 (1993-06-01), None
patent: WO-9314087 (1993-07-01), None
patent: WO-9506636 (1995-03-01), None
patent: WO-0228839 (2002-04-01), None
Street et al (1987): STN International HCAPLUS database, Columbus (Ohio), accession No. 1988: 55922.
A. Fuerstner et al. “Site Selective Formation of Low-Valent Titanum Reagents: an Instant Procedure for the Reductive Coupling of Oxo Amides to Indoles”J. Org. Chem.(1994) 59:5215-5229.
G. Foster et al. “The Reactions of Some Heterocyclic Quaternary Salts wit Potassium Cyanide”Chemical Comm.(1968) Bd. 22, S. 1440-1441.
A. Fuerstner et al. “Carbonyl Coupling Reactions Catalytic In Titanium and the Use of Commercial Titanium Powder for Organic Synthesis”J. Am. Chem. Soc.(1995) 117:4468-4475.
P. Chabrier et al. “Nitric oxide synthases: targets for therapeutic strategies in neurological diseases”Cell. Mol. Life Sci.(1999) 55:1029-1035.
A. Fuerstner et al. “Ethyl 5-chloro-3-phenylindole-2-carboxylate”Org. Synth.(1999) 76:142-150.
L. Lassen et al. “Nitric oxide synthase inhibition in migraine”The Lancet(1997) 349:401-402.
L. Thomsen et al. “Nitric Oxide Theory of Migraine”Clinical Neuroscience(1998) 5:28-33.
I. Green et al. “Nitric oxide: from basic research to clinical applications”DDT(1999) 4(2):47-49.
A. Hobbs et al. “Inhibition of Nitric Oxide Synthase as a Potential Therapeutic Target”Annu. Rev. Pharmacol. Toxicol.(1999) 39:191-220.
L. Ignarro “Stickstoffmonoxid: ein einzigartiges endogens Signalmolekuel in der Gafaeβbiologie (Novel-Vortrag)”Angew. Chem.(1999) 111:2002-2013.
F. Murad “Die Entdeckung einiger biologischer Wirkungen von Stickstoffmonoxid und seiner Rolle fuer die Zellkommunikation (Nobel-Vortrag)”Angrew. Chem.(1999) 111:1976-1989.
Buschmann Helmut
Hennies Hagen-Heinrich
Sundermann Bernd
Sundermann Corinna
Crowell & Moring LLP
Gruenenthal GmbH
Shameem Golam M. M.
LandOfFree
Substituted 2-pyrrolidine-2-yl-1H-indole compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted 2-pyrrolidine-2-yl-1H-indole compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2-pyrrolidine-2-yl-1H-indole compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3772439